CLDX - Celldex Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$51.00
DETAILS
HIGH:
$54.00
LOW:
$48.00
MEDIAN:
$51.00
CONSENSUS:
$51.00
UPSIDE:
65.96%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -17253.3% |
| EBITDA Margin | -17028.0% |
| Operating Margin | -19160.0% |
| Pretax Margin | -17253.3% |
| Cont. Ops Margin | -17253.3% |
| Net Margin | -17253.3% |
| Bottom Line Margin | -17253.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 10.49 |
| Quick Ratio | 10.49 |
| Solvency Ratio | -4.576 |
| Cash Ratio | 0.57 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-6.98
Peers avg: 4.5
|
| PEG Ratio | -0.12 |
| Forward PEG | -0.12 |
| Price/Book | 3.43 |
| Price/Sales | 1204.09 |
| Price/FCF | -8.45 |
| Price/Op Cash Flow | -8.56 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0040 |
| Debt/Equity | 0.0044 |
| Debt/Capital | 0.0044 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.11 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -4.137 |
| Operating Cash Flow/Sales | -14063.0% |
| Free Cash Flow/Operating Cash Flow | 101.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -164.57 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -135.92 |
| Operating Cash Flow Coverage | -90.30 |
| Capital Expenditure Coverage | -77.72 |
| Dividend + Capital Expenditure Coverage | -77.72 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.02 |
| EPS | -3.892 |
| Debt/Share | 0.0351 |
| Cash/Share | 7.80 |
| Book Value/Share | 7.93 |
| Tangible BV/Share | 7.52 |
| Equity/Share | 7.93 |
| Operating Cash Flow/Share | -3.172 |
| Capital Expenditure/Share | 0.041 |
| FCF/Share | -3.213 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.900 |
| Price/Fair Value | 3.43 |
| Debt/Market Cap | 0.0009 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -6.97 |